ICAR develops indigenous African Swine Fever vaccine, strengthening India’s biosecurity
Dr. M.L. Jat, Secretary, DARE and Director General, ICAR said that this breakthrough marks the dawn of a new era in veterinary science.
360° Perspective Analysis
Deep-dive into Geography, Polity, Economy, History, Environment & Social dimensions — AI-powered, on-demand
Context
The (ICAR), through its (NIHSAD) in Bhopal, has developed India's first indigenous MA-104 Cell Line-Based Live Attenuated vaccine for (ASF). This breakthrough addresses severe economic losses in the pig farming sector, particularly in Northeast India, caused by ASF outbreaks since 2020. The indigenous development reduces reliance on foreign, patented cell lines and lowers manufacturing costs.
UPSC Perspectives
Economic
The economic impact of livestock diseases is a critical component of agricultural economics in GS Paper 3. (ASF) is a highly contagious hemorrhagic viral disease of domestic and wild pigs with mortality rates approaching 100%. The article highlights significant financial losses: ₹276 crore in Assam (2020-2021) and ₹982 crore in Mizoram (up to 2025). These losses directly impact rural livelihoods, particularly for small and marginal farmers who rely on pig farming as a crucial income source. The development of an indigenous vaccine acts as a vital tool for risk mitigation, enhancing the resilience of the livestock sector. By significantly reducing pig mortality, the vaccine protects farmer incomes and ensures stability in the domestic meat market, contributing to broader goals of agricultural sustainability and poverty alleviation in rural areas.
Science and Technology
This development showcases advancements in biotechnology, specifically vaccine development, a key topic in GS Paper 3. The new ASF vaccine is a live attenuated vaccine (where the pathogen is weakened so it stimulates an immune response without causing disease). It utilizes a novel attenuated ASFV Genotype II virus with specific gene deletions. Crucially, it employs the widely available MA-104 cell line, rather than proprietary, patented cell lines used in commercially licensed vaccines from Vietnam. This technological independence represents a significant leap in indigenization (developing technology domestically). For UPSC, understanding the shift from reliance on foreign intellectual property to open-access cell lines is important, as it enables scalable, cost-effective domestic manufacturing. The thorough testing process—including checks for genetic stability, immunogenicity, and protective efficacy—demonstrates rigorous biosecurity and biosafety standards.
Governance
The successful development and validation of the vaccine highlight effective institutional collaboration, a crucial governance aspect. The (ICAR), acting as the apex body for coordinating agricultural research and education in India, led the scientific effort through its specialized institute, NIHSAD. Furthermore, the field validation was conducted in collaboration with the (DAHD). This synergistic approach between research institutions and implementing departments is essential for translating scientific discoveries into practical solutions. The state's role in promoting animal health security is paramount, as livestock health directly impacts food security and rural economies. From a policy perspective, this achievement aligns with the Make in India initiative, fostering self-reliance (Atmanirbhar Bharat) in critical sectors like veterinary medicine and biosecurity.